Screener
LeMaitre Vascular LMAT Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | (unaudited) / June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 220,207 | 222,174 |
| Stockholders’ equity: | ||
| Preferred stock, $0.01 par value; 3,000,000 shares authorized; none issued and outstanding | — | — |
| Common stock, $0.01 par value; 37,000,000 shares authorized, 24,494,202 and 24,396,904 shares issued, 22,864,935 and 22,772,607 shares outstanding, respectively | 245 | 244 |
| Additional paid-in capital | 236,161 | 228,407 |
| Retained earnings | 206,017 | 184,715 |
| Accumulated other comprehensive loss | (4,165) | (2,411) |
| Treasury stock, at cost; 1,629,267 and 1,624,297 shares, respectively | (17,916) | (17,439) |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's common stock?
- LeMaitre Vascular (LMAT) reported common stock of $245K in Q2 2026.
- How has LeMaitre Vascular's common stock changed year-over-year?
- LeMaitre Vascular's common stock increased by 1.2% year-over-year, from $242K to $245K.
- What is the long-term trend for LeMaitre Vascular's common stock?
- Over 5 years (2020 to 2025), LeMaitre Vascular's common stock has grown at a 2.0% compound annual growth rate (CAGR), from $221K to $244K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about LeMaitre Vascular's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude